Literature DB >> 9182952

Lymphocyte recruitment following spinal cord injury in mice is altered by prior viral exposure.

L Schnell1, R Schneider, M A Berman, V H Perry, M E Schwab.   

Abstract

The inflammatory response induced by mechanical lesion of the spinal cord is known to include the recruitment of neutrophils and macrophages, while the involvement of lymphocytes has been largely ignored. We have studied the pattern of lymphocyte recruitment following partial transection of the mouse spinal cord. Using immunohistochemical techniques, all three types of lymphocytes (CD4-positive T-cells, CD8-positive T-cells and B-cells) were found in the vicinity of the lesion site within hours and persisted for up to 7 days. There was a predominance of B-lymphocytes during the first 3 days. A second, late phase of cell infiltration, dominated by CD8-positive T-lymphocytes, occurred in mice that had been raised in a conventional breeding unit and had acquired antibody titres to a common murine virus (mouse hepatitis virus). In contrast, mice kept in specific pathogen-free facilities did not show this late-phase response. These findings suggest a possible role for lymphocytes in secondary tissue loss, local demyelination, scar formation, cytokine-mediated inflammatory responses or trophic processes. They also provide evidence that a virus infection can significantly enhance the reaction of T-cells to a spinal cord lesion.

Entities:  

Mesh:

Year:  1997        PMID: 9182952      PMCID: PMC7163543          DOI: 10.1111/j.1460-9568.1997.tb01450.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


central nervous system (animals raised in) conventional breeding unit mouse hepatitis virus specific pathogen‐free
  43 in total

Review 1.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

Review 2.  Macrophages and inflammatory damage in spinal cord injury.

Authors:  A R Blight
Journal:  J Neurotrauma       Date:  1992-03       Impact factor: 5.269

Review 3.  Microglia, the first line of defence in brain pathologies.

Authors:  G W Kreutzberg
Journal:  Arzneimittelforschung       Date:  1995-03

4.  Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination.

Authors:  R P Bunge; W R Puckett; J L Becerra; A Marcillo; R M Quencer
Journal:  Adv Neurol       Date:  1993

5.  Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family.

Authors:  A J McKnight; A J Macfarlane; P Dri; L Turley; A C Willis; S Gordon
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

6.  Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development.

Authors:  R L Coffman
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

7.  [Interferon stimulates the expression of cholinergic properties in human spinal cord neurons in culture].

Authors:  L Erkman; D Cadelli; L Wuarin; A C Kato
Journal:  Rev Neurol (Paris)       Date:  1988       Impact factor: 2.607

8.  Virological and immunological aspects of coronavirus induced subacute demyelinating encephalomyelitis in rats.

Authors:  H Wedge; R Watanabe; V ter Meulen
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

9.  Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat.

Authors:  D Bartholdi; M E Schwab
Journal:  Brain Res       Date:  1995-02-20       Impact factor: 3.252

10.  Demyelinating encephalomyelitis induced by a long-term corona virus infection in rats. A preliminary report.

Authors:  K Nagashima; H Wege; R Meyermann; V ter Meulen
Journal:  Acta Neuropathol       Date:  1979-03-15       Impact factor: 17.088

View more
  12 in total

1.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 2.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

3.  Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

Authors:  J Fisher; H Levkovitch-Verbin; H Schori; E Yoles; O Butovsky; J F Kaye; A Ben-Nun; M Schwartz
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 4.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

5.  Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

Authors:  E Hauben; O Butovsky; U Nevo; E Yoles; G Moalem; E Agranov; F Mor; R Leibowitz-Amit; E Pevsner; S Akselrod; M Neeman; I R Cohen; M Schwartz
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

Review 6.  Non-mammalian model systems for studying neuro-immune interactions after spinal cord injury.

Authors:  Ona Bloom
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

7.  Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.

Authors:  G Raivich; L L Jones; C U Kloss; A Werner; H Neumann; G W Kreutzberg
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

8.  Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes.

Authors:  Alpa Trivedi; Andrea D Olivas; Linda J Noble-Haeusslein
Journal:  Clin Neurosci Res       Date:  2006-12

9.  MicroRNA dysregulation in the spinal cord following traumatic injury.

Authors:  Mónica Yunta; Manuel Nieto-Díaz; Francisco J Esteban; Marcos Caballero-López; Rosa Navarro-Ruíz; David Reigada; D Wolfgang Pita-Thomas; Angela del Águila; Teresa Muñoz-Galdeano; Rodrigo M Maza
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

10.  Maximizing neuroprotection: where do we stand?

Authors:  Damien P Kuffler
Journal:  Ther Clin Risk Manag       Date:  2012-04-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.